A single arm, Multicenter study evaluating efficacy of beta 2-microglobulin adsorption column on dialysis-related amyloidosis - A single arm, Multicenter study evaluating efficacy of beta 2-microglobulin adsorption column on dialysis-related amyloidosis

Hirosaki University School of Medicine0 个研究点目标入组 30 人开始时间: 2018年5月1日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•Clinical evidence of any active cancer at Visit 1. Clinical evidence of cardiac conditions, including Angina requiring certain treatment with nitrates, unstable angina defined for study. History of significant central nervous system (CNS) injuries (including stroke or spinal cord injury) within 6 months of Visit 1. Use of any nitrates, cancer chemotherapy, androgens, antiandrogens, estrogens, luteinizing hormone-releasing hormone (LHRH) agonists/antagonists, or anabolic steroids at Visit 1. History of drug, alcohol, or substance abuse within the 6 months before Visit 1. Have any condition, limitation, or disease that could, in the judgment of the investigator, preclude evaluation of response to beta 2-microglobulin adsorption column.

发起方

Hirosaki University School of Medicine